Back to Boston Trust Walden Corp Boston Trust Walden Corp

ABBVABBV

Showing 9 of 31 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in AbbVie Inc.

Yes. Boston Trust Walden holds 25,878 shares of ABBV (AbbVie), worth $6.8M, as of its Q3 2026 13F filing. It reduced the position by 181 shares (-0.7%) from Q2 2026. Boston Trust Walden has held ABBV in every 13F on record since Q1 2019, 31 quarterly filings. ABBV is 0.1% of Boston Trust Walden's reported 13F portfolio.

Current Value

$6.8M

Current Shares

25,878

Total Value Change

+$1.6M

Total Shares Change

-162

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
25,878
-0.7%
$6.8M0.1%$259.99
0
2026-Q2
Increased
26,059
+1.3%
$6.6M0.0%$248.34
28
2026-Q1
Unchanged
25,726
0.0%
$5.6M0.0%$212.87
0
2025-Q4
Unchanged
25,726
0.0%
$5.9M0.0%$221.85
0
2025-Q3
Increased
25,726
+0.2%
$6M0.0%$223.20
27
2025-Q2
Decreased
25,678
-0.5%
$4.8M0.0%$177.40
0
2025-Q1
Increased
25,800
+0.8%
$5.4M0.0%$198.41
27
2024-Q4
Decreased
25,605
-1.7%
$4.6M0.0%$166.71
0
2024-Q3
Increased
26,040
+1.1%
$5.1M0.0%$183.80
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used